Alzheimer’s Association asks CMS to provide full coverage of FDA-approved dementia drugs
By
Kimberly Bonvissuto
Dec 21, 2022
Every day, more than 2,000 older adults living with mild dementia may transition to a more advanced stage of the disease and no longer be eligible for lecanemab and other antibodies targeting amyloid under...
PET changes similar for Alzheimer’s disease, Down syndrome
Dec 20, 2022
“This study shows that, although there are subtle differences, Alzheimer’s disease pathophysiology is similar among people with Down syndrome and people with autosomal dominant Alzheimer’s...
Drop in mortality seen with AChEI, memantine in dementia with Lewy bodies
Dec 14, 2022
Risk for death, unplanned hospital admission significantly lower for those taking AChEIs only or taking AChEIs and memantine
Review links hearing aid devices with reduced cognitive decline
Dec 06, 2022
Further, the use of devices is linked to a 3% improvement in cognitive test scores in the short term.
Memory care breakthrough, or yet another false alarm?
By
John O'Connor
Dec 01, 2022
This week’s Alzheimer’s revelation is a hopeful sign, but even under the best possible scenario, much work remains.
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.
Lecanemab reduced markers of amyloid in early Alzheimer’s disease
Dec 01, 2022
Moderately less decline was seen in cognition and function at 18 months with lecanemab versus placebo.
Lawmakers seek passage of two bills that would help prevent, treat Alzheimer’s
By
Kimberly Bonvissuto
Nov 22, 2022
Two lawmakers are asking for support of two bipartisan bills to ensure the nation has the ability to continue both immediate and long-term planning in its battle against Alzheimer’s disease and related...
Telmisartan linked to reduced risk for Alzheimer’s disease in Black patients
Nov 07, 2022
Black-specific beneficial effects of telmisartan were identified in a Mendelian randomization analysis.
More news for Monday, Nov. 7
By
Kimberly Bonvissuto
Nov 07, 2022
HUD opens 5th round of COVID supplemental payments, reduces reimbursements for senior housing … Front Porch expands memory care programs to meet increasing demand … Active adult data now available...